PNAGF yields 4.42% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, PNAGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PNAGF + JNJ for your $10,000?
PETRONAS Gas Berhad operates as a gas infrastructure and utilities company in Malaysia. The company engages in separating natural gas into components; and storing, transporting, distributing, and selling such components to industrial utilities. It operates through four segments: Gas Processing, Gas Transportation, Regasification, and Utilities. The Gas Processing segment processes natural gas from the gas fields of the East Coast of Peninsular Malaysia into sales gas and other by-products, such as ethane, propane, and butane. The Gas Transportation segment engages in the transportation of sales gas through its 2,623 kilometers of peninsular gas utilization pipeline network, as well as pengerang gas pipeline network. It also transports small volumes of sales gas through its gas distribution system in Miri and Bintulu, and Sarawak; exports sales gas to Singapore; and offers operation and maintenance services. The Regasification segment engages in the regasification of liquefied natural gas (LNG), as well as provides LNG reloading, truck loading, and gassing up and cooling down services. The Utilities segment manufactures, markets, and supplies industrial utilities to the petrochemical complexes in the Kertih and Gebeng Industrial Area. This segment offers electricity, steam, and industrial gases; and operations and maintenance services, as well as other utility products, such as oxygen, nitrogen, demineralized water, raw water, cooling water, and boiler feed water to petrochemical complexes and national electricity grid. The company was incorporated in 1983 and is based in Kuala Lumpur, Malaysia. PETRONAS Gas Berhad is a subsidiary of Petroliam Nasional Berhad.
Full PNAGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.